Respiratory Drugs - Market Insights, Competitive Landscape, and Industry Forecast to 2030; Featuring Company and Product Profiles of AstraZeneca, F. Hoffmann-La Roche, Teva Pharma, Novartis, GSK, and More
29 août 2024 05h37 HE
|
Research and Markets
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Drugs - Market Insights, Competitive Landscape, and Industry Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's...
Pfizer's ABRYSVO (RSVpreF) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032
30 avr. 2024 04h40 HE
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "ABRYSVO Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
RSV Vaccine Market To Reach USD 2.2 Billion By 2032 | DataHorizzon Research
18 avr. 2024 06h10 HE
|
DataHorizzon Research
Fort Collins, Colorado, April 18, 2024 (GLOBE NEWSWIRE) -- Growing prevalence of RSV in the population drives the need for RSV vaccines. RSV, a prevalent respiratory virus, often leads to severe...
Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030, Featuring Profiles of GSK, Novavax, SPI Pharma (Associated British Foods), Agenus, and CSL Among Others
10 avr. 2024 04h05 HE
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering.The...
Recombinant Vaccines Research Report 2024: Market Poised for Accelerated Growth, Set to Reach $34.18 Billion by 2034 from $10.14 Billion in 2023
31 janv. 2024 11h23 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
Vaccine Adjuvants Industry Forecast to 2034: A $7.36 Billion Market Opportunity, Dominated by Merck & Co, Thermo Fisher Scientific, and Pacific GeneTech
24 janv. 2024 14h18 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global vaccine...
Global Respiratory Disease Vaccine Research Report 2023: A $70+ Billion Industry by 2030 - Increasing Prevalence and Growing Focus on Prevention Bolsters Growth
12 déc. 2023 03h13 HE
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report By Type (Viral, Bacterial, Combination), By Age Group, By Infection...
DHSS launches interactive statewide flu dashboard
13 oct. 2023 17h00 HE
|
Missouri Department of Health and Senior Services
JEFFERSON CITY, Mo., Oct. 13, 2023 (GLOBE NEWSWIRE) -- The Missouri Department of Health and Senior Services (DHSS) has published the first Weekly Influenza Surveillance Report of the 2023-2024 flu...
High Prevalence of RSV in Infants and Elderly Pushes RSV Vaccine and Antibody Market Growth - Forecast to 2030
28 sept. 2023 04h58 HE
|
Research and Markets
Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Forecast up to 2030" report has been added to ResearchAndMarkets.com's...